GILDER GAGNON HOWE & CO LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 149 filers reported holding THERAPEUTICSMD INC in Q4 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q4 2017$1,492,000
-88.6%
246,969
-90.0%
0.02%
-89.1%
Q3 2017$13,070,000
-18.2%
2,470,766
-18.6%
0.18%
-22.0%
Q2 2017$15,987,000
-27.4%
3,033,680
-0.9%
0.24%
-36.6%
Q1 2017$22,030,000
+11.9%
3,059,690
-10.3%
0.37%
-4.1%
Q4 2016$19,682,000
-20.5%
3,411,162
-6.2%
0.39%
-8.9%
Q3 2016$24,763,000
-41.3%
3,636,325
-26.7%
0.43%
-49.2%
Q2 2016$42,169,000
+30.6%
4,961,043
-1.7%
0.84%
+32.2%
Q1 2016$32,292,000
-38.9%
5,045,685
-1.1%
0.63%
-25.4%
Q4 2015$52,885,000
+74.8%
5,099,855
-1.2%
0.85%
+77.1%
Q3 2015$30,252,000
-25.7%
5,162,538
-0.4%
0.48%
-10.3%
Q2 2015$40,741,000
+10.6%
5,183,327
-14.9%
0.54%
+4.5%
Q1 2015$36,847,000
+38.1%
6,090,445
+1.6%
0.51%
+29.0%
Q4 2014$26,678,000
-5.7%
5,995,066
-1.7%
0.40%
-3.4%
Q3 2014$28,287,000
+4.3%
6,096,382
-0.7%
0.41%
+14.2%
Q2 2014$27,123,000
-30.2%
6,136,366
-0.4%
0.36%
-31.9%
Q1 2014$38,858,000
-1.2%
6,158,085
-18.4%
0.53%
-5.7%
Q4 2013$39,323,000
+310.0%
7,547,644
+130.6%
0.56%
+274.0%
Q3 2013$9,592,000
-99.4%
3,273,598
+536.1%
0.15%
+417.2%
Q2 2013$1,559,286,000514,6160.03%
Other shareholders
THERAPEUTICSMD INC shareholders Q4 2016
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 3,560,816$2,641,0000.48%
Rubric Capital Management LP 5,344,302$3,962,0000.11%
Birchview Capital, LP 100,000$74,0000.05%
C WorldWide Group Holding A/S 6,189,834$4,589,0000.05%
MCDONALD PARTNERS LLC 226,000$168,0000.04%
Traynor Capital Management, Inc. 367,991$272,0000.04%
Platform Technology Partners 100,000$74,0000.03%
EMFO, LLC 44,500$33,0000.03%
Knights of Columbus Asset Advisors LLC 365,105$271,0000.02%
Kowal Investment Group, LLC 98,631$73,0000.02%
View complete list of THERAPEUTICSMD INC shareholders